NASDAQ
IN8bio, Inc. (INAB) has a free cash flow growth of -131.70% as of Friday, May 29, 2026. This represents a 1223.17% decrease compared to its 12-month average of 11.73%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.